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Kaposi's Sarcoma-Associated Herpesvirus (KSHV), also
known as human Herpesvirus 8, is associated with several
malignant disorders, including Kaposi's sarcoma, primary
effusion lymphoma (PEL) and multicentric Castleman's
disease. KSHV ORF-K9 encodes viral interferon regulatory
factor 1 (vIRF1), an early lytic gene product homologous
to cellular interferon regulatory factors. The IRF family
members are transcription regulatory factors that bind to
interferon-stimulated response elements (ISRE) to regu-
late interferon-responsive genes involved in pathogen
response, cytokine signaling, cell growth regulation, and
hematopoietic development. As an oncogenic protein,
vIRF1 potentially contributes to KSHV-driven malignan-
cies. In this study, KSHV vIRF1 was suppressed with pep-
tide-conjugated antisense phosphorodiamidate
morpholino oligonucleotides (PPMO) and the effect was
examined. PPMO are single-stranded DNA analogues that
have a modified backbone and which penetrate cells read-
ily. Treatment of PEL cells with anti-K9 PPMO led to
reduction of vIRF1 expression. The anti-K9 PPMO also
reduced expression of vIRF1 in 293 cells transiently trans-
fected with a K9 plasmid. PEL cells that were treated with
anti-K9 PPMO exhibited reduced RTA and vIL-6 expres-
sion and reduced level of KSHV DNA copies. The inhibi-
tion of vIRF1 in PEL cells led to elevation of protein levels
of important genes in IFN signaling, including IRF3 and
STAT1, indicating the activation of the pathway. The
results demonstrate that targeting of vIRF1 mRNA with
PPMO can potently reduce vIRF1 protein translation, and
indicate that further exploration of these compounds in
an animal model is warranted.
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